Archives - June 03, 2025

	Indian Innovation vs Western Monopolies: Lupin’s FDA Triumph Tells a Bigger Story Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ... Jun 03
	When Sweat Beats the Scalpel: How a Pair of Sneakers Can Outperform the Most Expensive Cancer Drugs Cancer patients would no longer be passive recipients of care but active participants in their own healing.... Jun 03
	How Climate Change Is Endangering India’s Pregnant Women If the country truly wishes to protect its next generation, it must start by shielding the mothers of today.... Jun 03
	HCG Manavata Cancer Centre Performs First-Ever PIPAC Surgery In Nashik Minimally Invasive Treatment Brings New Hope For Advanced Cancer Patients.... Jun 03
	Traditional Chinese Medicine Consumption Shows Promising Outlook, with Neautus's Market Leadership Becoming Increasingly Evident In 2025, the policies regarding traditional Chinese medicine (TCM) in Mainland China are being continuously optimized, providing broader opportunities for the consumer TCM market. ... Jun 03
	Empowering Indian Nurses for Global Careers: TERN and TNAI Launch Free Residential German Training Program’s Second Batch TERN Group x TNAI: A fully-sponsored initiative to train and place Indian nurses in Germany — at no cost to the candidates, powered by ethical ... Jun 03
6 Stories found!